Delivery Order SPE2D021DA002-SPE2D325F004G
Award Date
4/18/25
Potential Completion Date
4/21/25
Potential Value
$1.4K
Federal Agency
Medical Supply Chain
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,429.30, is for the delivery of ISENTRESS 400 MG tablets, a prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which has a ceiling value of $499,999,999 and is valid...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of ISENTRESS 400 MG TABLET. The $2,858.60 order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA to issue delivery orders for a broad range of pharmaceutical products, including branded and generic prescription drugs,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for $2,858.60. The contract is for the supply of ISENTRESS 400 MG TABLET, a prescription medication, with a period of performance through March 19, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,143.51, is for the delivery of the pharmaceutical product ISENTRESS 400 MG TABLET. The contract has a firm fixed-price pricing type and a period of performance that runs through May 8, 2024. This order is issued under a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of the pharmaceutical product Isentress 400 mg Tablet, with a potential value of $2,325.64. This delivery order is part of a larger indefinite delivery contract between DMS Pharmaceutical Group and DLA to provide a variety of pharmaceutical items and medical supplies to military treatment...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of pharmaceutical products. The contract has a ceiling value of $1,381.17 and an ultimate completion date of March 13, 2024. The contract includes the delivery of Isentress 400 mg tablets and is part of a larger indefinite delivery vehicle (IDV) contract, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $2,762.34 contract is for the delivery of Isentress 400 mg tablets, a pharmaceutical product. The contract has no set-aside designation. DMS Pharmaceutical Group holds a separate $4,999,999 indefinite delivery contract with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, for the delivery of ISENTRESS 400 MG TABLET. The total ceiling value of the award is $4,143.51, with a completion date of March 12, 2024. This delivery order is placed against DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, contract 4600082013 under the SPE2DB program, which has a total potential value of up...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,902.13, is for the delivery of Isentress 100 mg Tablet Chewable (National Drug Code 00006-0548-41) to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a $1,381.17 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of ISENTRESS 400 mg tablets, with a period of performance through May 17, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which...